Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

People with alopecia areata may have a higher risk of thyroid diseases.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Sudden, unusual hair loss may indicate serious underlying health issues.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Infliximab may cause hair loss in Crohn's disease patients.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Timely diagnosis and treatment of complex autoimmune diseases like APS2 are crucial to prevent complications and improve life quality.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Genetic discoveries are leading to new treatments for alopecia areata.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.